Janssen Pharma Enters Deal With U.S. Government On 100 Mln Doses Of COVID-19 Vaccine

(RTTNews) - Johnson & Johnson (JNJ) said Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of SARS-CoV-2 investigational vaccine, Ad26.COV2.S, for use in the United States following approval. The U.S. government may also purchase an additional 200 million doses of Ad26.COV2.S under a subsequent agreement.

"We are scaling up production in the U.S. and worldwide to deliver a SARS-CoV-2 vaccine for emergency use," said Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson.